Clinical Trial Details
— Status: Recruiting
Administrative data
| NCT number |
NCT00001506 |
| Other study ID # |
960102 |
| Secondary ID |
96-AR-0102 |
| Status |
Recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
August 22, 1996 |
Study information
| Verified date |
May 14, 2024 |
| Source |
National Institutes of Health Clinical Center (CC) |
| Contact |
Kelli A Karacki, P.A.-C |
| Phone |
(301) 402-7806 |
| Email |
kelli.karacki[@]nih.gov |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
This is a training, natural history of disease, and screening protocol for the evaluation,
treatment and follow-up of patients with dermatologic diseases and systemic diseases with
cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated
according to generally available, standard procedures and therapeutic modalities. Samples of
blood and skin will be studied by routine and specialized investigative methods to establish
these patients' diagnosis, response to treatment, and/or disease progression.
Description:
Background
This is a training, natural history of disease, and screening protocol for the evaluation,
treatment and follow-up of patients with dermatologic diseases and systemic diseases with
cutaneous manifestations. This protocol was developed to allow subject enrollment for
teaching purposes and to allow for second opinions regarding relatively complicated patients,
and to allow for evaluation of non-invasive tools for the diagnosis and monitoring of
cutaneous manifestations. This protocol promotes a critical link between the NCI, CCR
Dermatology Branch and the local and national extramural medical communities.
Objectives:
- To provide clinical material to fulfill the educational mission of the Dermatology
Branch.
- To learn about the natural history of selected dermatologic diseases.
Eligibility:
All subjects regardless of age, gender, or racial/ethnic group with dermatologic disease or
systemic disease with cutaneous manifestations.
Design:
Patients enrolled in this protocol will be evaluated and treated according to generally
available, standard procedures and therapeutic modalities. Samples of blood and skin will be
studied by routine and specialized investigative methods to establish these patients
diagnosis, response to treatment, and/or disease progression. Non-invasive tools may be used
as part of the examination and assessment of cutaneous manifestations of disease.
Other known NCT identifiers
